doxazosin has been researched along with tamsulosin in 98 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (13.27) | 18.2507 |
2000's | 50 (51.02) | 29.6817 |
2010's | 29 (29.59) | 24.3611 |
2020's | 6 (6.12) | 2.80 |
Authors | Studies |
---|---|
Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
Altenbach, RJ; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Condon, S; Drizin, I; Elmore, SW; Hancock, AA; Kerwin, JF; Meyer, MD; Sippy, KB; Tietje, K; Wendt, MD | 1 |
Altenbach, RJ; Bai, H; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Hancock, AA; Kerwin, JF; Lebold, SA; Lee, E; Meyer, MD; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG | 1 |
Chapple, CR | 2 |
Chalmers, DH; Kenny, BA; Miller, AM; Naylor, AM; O'Connell, J; Williamson, IJ | 1 |
Fujimura, A; Harada, K; Ohmori, M | 1 |
Brune, ME; Buckner, SA; Hancock, AA; Ireland, LM; Katwala, SP; Kerwin, JF; Milicic, I | 1 |
Andersson, KE; Lepor, H; Wyllie, MG | 1 |
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I | 1 |
Beduschi, MC; Beduschi, R; Oesterling, JE | 2 |
Kim, SC; Lee, MY; Lim, SW; Seo, KK | 1 |
Wyllie, MG | 2 |
Clifford, GM; Farmer, RD | 1 |
Benning, CM; Kyprianou, N | 2 |
Benning, CM; Chon, J; Kyprianou, N | 1 |
Caprino, L | 1 |
Cotecchia, S; Goepel, M; Hein, P; Michel, MC | 1 |
Dutkiewics, S | 1 |
Bahnson, RR; Dull, P; Reagan, RW | 1 |
Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 1 |
Keledjian, K; Kyprianou, N | 1 |
Kirby, RS | 1 |
Romics, I | 1 |
Barqawi, A; Crawford, ED; Gamito, E; O'Donnell, C | 1 |
Jensen, D; Kirby, RS; Mallen, S; Quinn, S | 1 |
Doggrell, SA | 1 |
Kyprianou, N; Rowland, RG; Tahmatzopoulos, A | 1 |
Barnett, G; Brown, CT; Ellis, BW; Emberton, M; Ryan, M; Watson, V | 1 |
Bedding, A; Emmick, JT; Jackson, G; Kloner, RA; Mitchell, MI; Pereira, A; Warner, MR | 1 |
Mazo, EB; Shashin, MN | 1 |
Combs, AJ; Donohoe, JM; Glassberg, KI | 1 |
Desgrandchamps, F; Fitzpatrick, JM | 1 |
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E | 1 |
Muradian, AA | 1 |
Basar, H; Basar, MM; Batislam, E; Ferhat, M; Tuglu, D; Yilmaz, E | 1 |
Bae, JH; Jung, PB; Lee, JG | 1 |
Athanasopoulos, A; Perimenis, P | 1 |
Afshari, NA; Schwinn, DA | 1 |
Irani, J | 1 |
de la Rosette, JJ; Michel, MC; van Dijk, MM | 1 |
de la Rosette, JJ; Michel, MC | 1 |
O'Leary, MP | 1 |
Bertero, E; Cairoli, CE; DA Ros, CT; Damião, R; Koff, WJ; Mesquita, F; Pinheiro, GE; Pompeo, AC; Rosenblatt, C; Wroclawski, ER | 1 |
Cho, TW; Hong, YK; Jang, WK; Lee, YK; Lee, YT; Park, DS | 1 |
Birowo, P; Djati, W; Rahardjo, D; Soebadi, DM; Sugandi, S; Wahyudi, I | 1 |
Ding, Q; He, Z; Wang, J; Xu, K; Xue, Z; Zhang, Y | 1 |
Herd, MK | 1 |
Akova, YA; Altan-Yaycioglu, R; Ozkardes, H; Tufan, H; Yaycioglu, O | 1 |
Awan, MA; Cheung, CM; Peh, KK; Sandramouli, S | 1 |
Shaplygin, LV | 1 |
Darstein, C; Guillaume, M; Jimenez, MC; Lonsdale, F; Mitchell, MI | 1 |
Jin, J; Kong, CZ; Li, NC; Na, YQ; Qiu, SP; Song, YS; Sun, G; Sun, YC; Sun, YH; Wang, XF; Wu, SL; Ye, ZQ | 1 |
Kitteringham, NR; Macdonald, I; Park, BK; Randle, LE; Sathish, JG; Williams, DP | 1 |
Arikan, G; Bozkurt, O; Demir, O; Durak, I; Esen, A; Saatci, AO; Yaman, A | 1 |
Mamalis, N | 1 |
Andersson, KE | 1 |
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ | 1 |
Kaplon, DM; Nakada, SY; Sterrett, S | 1 |
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA | 1 |
Chung, BH; Lee, SH; Mah, SY; Park, KK | 1 |
Chatziralli, IP; Sergentanis, TN | 1 |
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H | 1 |
Krome, S | 1 |
Dargallo, T; Gómez Veiras, JR; González, M; Molina Vázquez, ME; Pais, E; Palacios, MG; Somoza Arguibay, I; Tellado, M; Vela, D | 1 |
Du, H; He, L; Ren, J; Wang, S | 1 |
Jin, J; Wan, B; Wang, X; Yang, Y; Ye, H; Yu, W; Zhang, K; Zhang, N; Zhong, C | 1 |
Casuccio, A; Cillino, G; Cillino, S; Pavone, C; Spitale, E | 1 |
Fareed, K; Fouda, K; Gaafar, S; Marzouk, E; Yakoubi, R; Zahran, AR; Zaytoun, OM | 1 |
Chung, BH; Chung, MS; Lee, SH; Park, KK; Yoo, SJ | 1 |
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW | 1 |
Liu, Y; Mao, C; Qin, X; Yang, K; Yang, Z; Yuan, J | 1 |
Al-Ahmar, B; Haridas, A; Hingorani, M; Syrimi, M | 1 |
Araki, M; Araki, T; Monden, K | 1 |
Borgia, JA; Gaynes, BI; Gaynes, JS; Micic, C | 1 |
Carini, M; Corona, G; Ficarra, V; Gacci, M; Maggi, M; Novara, G; Sebastianelli, A; Serni, S; Shariat, SF; Zattoni, F | 1 |
Fisher, E; Omar, MI; Subramonian, K | 1 |
Graybill, SD; Vigersky, RA | 1 |
Barkin, J; Berner, T; Diles, D; Franks, B | 1 |
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P | 1 |
Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C | 1 |
Cao, Y; Chen, T; Guo, L; Niu, H; Wang, Y; Yang, X | 1 |
Afsar Yildirim, M; Akdeniz, F; Bozkurt, O; Çelik, S; Demir, O; Gursoy Bulut, M; Hacihasanoglu, ML | 1 |
Wang, XP | 1 |
Bourdoumis, A; Buchholz, N; Dräger, D; Durner, L; Füllhase, C; Hakenberg, OW | 1 |
Hori, Y; Ohyama, K; Sugiura, M | 1 |
Dahm, P; Hwang, EC; Koziarz, A; Kuntz, GM; Oestreich, MC; Sathianathen, NJ; Scales, CD; Vernooij, RW | 1 |
Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ | 1 |
Athey, S; Bai, R; Bettegowda, C; Caffo, B; Carrero, JJ; Fischer, N; Huq, S; Khalafallah, AM; Kinzler, KW; Koenecke, A; Konig, MF; Mensh, BD; Nishimura, A; Papadopoulos, N; Powell, M; Shen, Z; Sparen, P; Staedtke, V; Stuart, EA; Thomas, DL; Trevisan, M; Vogelstein, B; Vogelstein, JT; Xiong, R; Zhou, S | 1 |
Guo, J; Tang, R | 1 |
Amorim, AC; Antunes, E; Britto-Júnior, J; Campos, R; da Silva-Filho, WP; De Nucci, G; Fregonesi, A; Monica, FZ; Moraes, MEA; Moraes, MO | 1 |
Baldassarri, V; Cicione, A; D'Annunzio, S; DE Nunzio, C; Franco, A; Guarnotta, G; Lombardo, R; Mancini, E; Nacchia, A; Rovesti, LM; Tema, G; Tubaro, A; Voglino, OA | 1 |
29 review(s) available for doxazosin and tamsulosin
Article | Year |
---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Clinical Trials as Topic; Doxazosin; Half-Life; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Vasodilation | 1996 |
Prostatic alpha 1-adrenoceptors and uroselectivity.
Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Male; Prazosin; Prostate; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin | 1997 |
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 1997 |
Benign prostatic hyperplasia: use of drug therapy in primary care.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Primary Health Care; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 1998 |
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 1998 |
Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 1998 |
Medical therapy for benign prostatic hyperplasia: a review of the literature.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2000 |
[Drugs for the treatment of benign prostatic hypertrophy].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Androgen Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Muscle, Smooth; Plant Extracts; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Serenoa; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urodynamics | 2000 |
Managing benign prostatic hyperplasia.
Topics: Complementary Therapies; Doxazosin; Humans; Male; Palpation; Prostatectomy; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urine | 2002 |
[Pharmacologic treatment of benign prostatic hyperplasia].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2003 |
The role of alpha-blockers in the management of prostate cancer.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiogenesis Inhibitors; Anoikis; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Sulfonamides; Tamsulosin | 2004 |
The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Clinical Trials as Topic; Delayed-Action Preparations; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome | 2005 |
One drug fits all.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Drug Combinations; Drug Industry; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypertension; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2005 |
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases | 2005 |
Effects of alpha(1)-adrenoceptor antagonists on male sexual function.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Antagonists; Adult; Aged; Doxazosin; Ejaculation; Erectile Dysfunction; Humans; Libido; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin | 2006 |
Treatment and pharmacologic management of BPH in the context of common comorbidities.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome | 2006 |
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].
Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2008 |
Risk factors for intraoperative floppy iris syndrome: a meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin | 2011 |
[How effective is finasteride?].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin | 2011 |
The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews.
Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2013 |
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Ejaculation; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urological Agents | 2014 |
The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adult; Device Removal; Doxazosin; Humans; Indoles; Male; Quinazolines; Randomized Controlled Trials as Topic; Recovery of Function; Sulfonamides; Tamsulosin; Urinary Catheterization; Urinary Retention; Urination | 2014 |
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics | 2016 |
[Therapeutic effects of α-adrenergic receptor antagonists on benign prostatic hyperplasia: A network meta-analysis].
Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoles; Male; Network Meta-Analysis; Prostatic Hyperplasia; Quality of Life; Sexual Dysfunction, Physiological; Tamsulosin | 2018 |
The Evidence Paradox of the Effectiveness between the Paediatric and Adult Stone-Forming Population: A Narrative Review.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Age of Onset; Child; Doxazosin; Evidence-Based Medicine; Female; Humans; Male; Quinazolines; Remission Induction; Tamsulosin; Treatment Outcome; Urolithiasis; Urological Agents | 2019 |
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxazosin; Humans; Indoles; Kidney Calculi; Lithotripsy; Middle Aged; Prazosin; Quinazolines; Randomized Controlled Trials as Topic; Tamsulosin; Ureteral Calculi | 2020 |
Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis.
Topics: Doxazosin; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urological Agents | 2021 |
20 trial(s) available for doxazosin and tamsulosin
Article | Year |
---|---|
Comparison of the antagonistic activity of tamsulosin and doxazosin at vascular alpha 1-adrenoceptors in humans.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Cold Temperature; Cross-Over Studies; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Phenylephrine; Regional Blood Flow; Sulfonamides; Tamsulosin; Vasoconstriction | 1996 |
alpha1-adrenoceptor selectivity: the North American experience.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prostate; Single-Blind Method; Sulfonamides; Tamsulosin; Urethra | 1999 |
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders | 2002 |
A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2003 |
Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis.
Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2004 |
Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia.
Topics: Clinical Trials as Topic; Doxazosin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2004 |
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Aged; Carbolines; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Doxazosin; Drug Interactions; Hemodynamics; Humans; Male; Middle Aged; Phosphoric Diester Hydrolases; Sulfonamides; Tadalafil; Tamsulosin | 2004 |
[Alfa-blockade with doxazosin vs tamsulozin in combination of intermittent androgen blockade in patients with prostate cancer].
Topics: Adrenergic alpha-Antagonists; Aged; Androgen Antagonists; Antineoplastic Agents; Doxazosin; Drug Therapy, Combination; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urodynamics | 2005 |
The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Doxazosin; Female; Humans; Male; Middle Aged; Pain Measurement; Prazosin; Sulfonamides; Tamsulosin; Treatment Outcome; Ureteral Calculi | 2005 |
A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil.
Topics: Adrenergic alpha-Antagonists; Aged; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome | 2006 |
Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Botulinum Toxins, Type A; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Neuromuscular Agents; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2006 |
Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Doxazosin; Heart Rate; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urethral Diseases; Urinary Bladder Neck Obstruction; Urodynamics | 2006 |
Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: a study in Chinese patients.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; China; Delayed-Action Preparations; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2007 |
Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Carbolines; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Interactions; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Sulfonamides; Tadalafil; Tamsulosin | 2007 |
[Comparison of different drugs on the treatment of benign prostate hyperplasia].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androstadienes; Double-Blind Method; Doxazosin; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prazosin; Prostate; Prostatic Hyperplasia; Quality of Life; Secale; Sulfonamides; Tamsulosin; Treatment Outcome | 2007 |
Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Doxazosin; Humans; Male; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2011 |
Tamsulosin and doxazosin as adjunctive therapy following shock-wave lithotripsy of renal calculi: randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Combined Modality Therapy; Doxazosin; Female; Humans; Kidney Calculi; Lithotripsy; Male; Middle Aged; Prospective Studies; Sulfonamides; Tamsulosin | 2012 |
Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2011 |
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2013 |
A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Tolterodine Tartrate | 2016 |
49 other study(ies) available for doxazosin and tamsulosin
Article | Year |
---|---|
Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH).
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cell Line; Dogs; Heterocyclic Compounds, 3-Ring; Indoles; Male; Pressure; Prostatic Hyperplasia; Radioligand Assay; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Urethra | 2000 |
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Dogs; Doxazosin; Drug Design; Humans; Indicators and Reagents; Indoles; Isoindoles; L Cells; Male; Mice; Models, Molecular; Molecular Conformation; Prazosin; Prostate; Prostatic Hyperplasia; Quinazolines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Spleen; Structure-Activity Relationship; Vas Deferens | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin | 1994 |
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Prazosin; Pressure; Prostate; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin | 1996 |
Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Doxazosin; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Urethra | 1996 |
Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Doxazosin; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Prazosin; Rabbits; Sulfonamides; Tamsulosin | 1999 |
Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cells, Cultured; Doxazosin; Growth Inhibitors; Humans; Male; Mice; Mice, SCID; Muscle, Smooth; Neoplasm Transplantation; Prazosin; Prostate; Prostatic Neoplasms; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tamsulosin; Transplantation, Heterologous | 2000 |
Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Biopsy; Cell Division; Doxazosin; Humans; Male; Muscle, Smooth; Prazosin; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Sulfonamides; Tamsulosin | 2000 |
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium | 2001 |
Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2001 |
Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tumor Cells, Cultured | 2002 |
Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anoikis; Cell Adhesion; Cell Survival; Doxazosin; Endothelial Growth Factors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Neoplasm Invasiveness; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tamsulosin; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Herbal and vitamin supplement use in a prostate cancer screening population.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Colorado; Complementary Therapies; Dietary Supplements; Doxazosin; Drug Utilization; Family; Finasteride; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Penile Erection; Phytotherapy; Plant Preparations; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Self Medication; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders; Vitamins | 2004 |
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Azasteroids; Doxazosin; Dutasteride; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders | 2004 |
[Use of alpha-adrenoblockers in therapy of benign prostatic hyperplasia in patients with arterial hypertension].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Antineoplastic Agents; Doxazosin; Humans; Hypertension; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2004 |
Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Child; Child, Preschool; Doxazosin; Electromyography; Female; Humans; Male; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urination Disorders; Urodynamics | 2005 |
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics | 2004 |
The effects of alpha-adrenoceptor antagonists on the urethral perfusion pressure of the female rat.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Doxazosin; Female; Male; Muscle Contraction; Muscle, Smooth; Phentolamine; Pressure; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin; Urethra; Urinary Bladder Neck Obstruction | 2005 |
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2005 |
Are all alpha-blockers created the same?
Topics: Adrenergic alpha-Antagonists; Adult; Clinical Trials as Topic; Dizziness; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2006 |
alpha-blocker treatment of urolithiasis.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Drug Therapy, Combination; Glucocorticoids; Humans; Prazosin; Sulfonamides; Tamsulosin; Urolithiasis | 2006 |
Intraoperative floppy-iris syndrome with doxazosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Prospective Studies; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin | 2007 |
The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Doxazosin; Iris; Male; Prazosin; Pupil; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin | 2007 |
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist.
Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cataract Extraction; Doxazosin; Female; Humans; Hypertension; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2007 |
[Using of alpha1-adrenoreceptor blockers in urologic practice].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Doxazosin; Humans; Middle Aged; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics | 2007 |
alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice.
Topics: Acetaminophen; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Catecholamines; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Doxazosin; Erythrocytes; Gene Expression Regulation, Enzymologic; Glutamate-Cysteine Ligase; Glutathione; Heme Oxygenase-1; Liver; Liver Circulation; Liver Diseases; Male; Membrane Proteins; Mice; Prazosin; Protein Binding; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Time Factors; Transaminases | 2008 |
The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2008 |
Intraoperative floppy-iris syndrome associated with systemic alpha blockers.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2008 |
How many drugs for LUTS due to BPH are too many?
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Imidazoles; Male; Muscarinic Antagonists; Phenylpropanolamine; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Tolterodine Tartrate; Triazines; Urination Disorders; Vardenafil Dihydrochloride | 2008 |
Medical management of acute urolithiasis in one American academic emergency room.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Child; Doxazosin; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome; Urolithiasis; Young Adult | 2010 |
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin | 2010 |
Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.
Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Drug Combinations; Humans; Hypertension; Male; Middle Aged; Models, Biological; Polypharmacy; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin | 2010 |
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography | 2011 |
[Role of alpha antagonists in uncoordinated micturition syndrome in childhood].
Topics: Adrenergic alpha-1 Receptor Antagonists; Child; Child, Preschool; Doxazosin; Female; Humans; Male; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin; Urination Disorders | 2010 |
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.
Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin | 2011 |
Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cohort Studies; Doxazosin; Drug Combinations; Humans; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prazosin; Predictive Value of Tests; Prospective Studies; Pupil; Risk Factors; Sensitivity and Specificity; Sulfonamides; Syndrome; Tamsulosin; Tropicamide | 2011 |
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin | 2012 |
Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates.
Topics: Adrenergic alpha-1 Receptor Antagonists; Atropine; Doxazosin; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin; United Kingdom | 2013 |
Quantitation of in vitro α-1 adrenergic receptor antagonist binding capacity to biologic melanin using tandem mass spectrometry.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Biological Assay; Cattle; Chloroquine; Choroid; Doxazosin; In Vitro Techniques; Iris; Melanins; Protein Binding; Retinal Pigment Epithelium; Sulfonamides; Tamsulosin; Tandem Mass Spectrometry | 2013 |
Effects of α-blocker therapy on active duty military and military retirees for benign prostatic hypertrophy on diabetic complications.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Doxazosin; Humans; Male; Middle Aged; Military Personnel; Prostatic Hyperplasia; Retirement; Retrospective Studies; Sulfonamides; Tamsulosin; United States | 2015 |
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate | 2015 |
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin | 2016 |
Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Doxazosin; Female; Flank Pain; Humans; Indoles; Male; Middle Aged; Quinazolines; Retrospective Studies; Tadalafil; Tamsulosin; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Calculi; Urological Agents; Young Adult | 2018 |
Evaluation of syncope association with α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin | 2019 |
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States | 2021 |
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Doxazosin; Humans; Male; Middle Aged; Pneumonia, Viral; Respiration, Artificial; Respiratory Distress Syndrome; Retrospective Studies; Sweden; Tamsulosin; United States | 2021 |
6-nitrodopamine is a major endogenous modulator of human vas deferens contractility.
Topics: Adrenergic Antagonists; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Chromatography, Liquid; Desipramine; Dopamine; Doxazosin; Epinephrine; Humans; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Prazosin; Rats; Receptors, Adrenergic; Tamsulosin; Tandem Mass Spectrometry; Vas Deferens | 2022 |
Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Hypotension, Orthostatic; Prazosin; Tamsulosin; Urogenital Diseases | 2023 |